The prognostic power of model 5 was increased by adding immune response indicators (likelihood ratio 29.03 of model 5 compared with 17.64 of model 4), where higher CD8 density in the tumor aspect of IZ predicted better OS. The gene discussed is CD8A; the disease is neoplasm.